Clinical Trial

Autoimmune Basis for Postural Tachycardia Syndrome

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test the hypothesis that an antibody-mediated autoimmune reaction will cause symptoms of autonomic dysfunction in some patients with postural tachycardia syndrome (POTS). The investigators further hypothesize that electrical stimulation of the vagus nerve will improve POTS symptoms, autoimmunity and inflammation.
Protocol Amendment History 1 change
critical Trial completed 2026-07-30
Trial Details
NCT Number NCT05043051
Lead Sponsor University of Oklahoma
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Postural Tachycardia Syndrome
Enrollment 80 participants
Start Date 2022-01-14
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-29